​
​

Kintara Therapeutics Ownership | Who Owns Kintara Therapeutics?

OverviewRevenueFinancialsChart

Kintara Therapeutics Ownership Summary

Kintara Therapeutics is owned by 4.76% institutional investors, and 95.24% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.57% of its assets in Kintara Therapeutics shares.

KTRA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKintara Therapeutics4.76%-95.24%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20222321.05%3,488,056-0.11%49.27%1025.00%4-
Jun 30, 202219-13.64%3,491,7370.79%714.42%860.00%4-
Mar 31, 202222-12.00%3,464,522-11.77%710.77%5-66.67%4300.00%
Dec 31, 202125-7.41%3,926,522-26.71%83.31%157.14%1-85.71%
Sep 30, 2021278.00%5,357,51492.56%1517.30%14-6.67%7250.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index314.70K0.57%11.67K
Fidelity Series Total Market Index54.12K0.10%-
Fidelity Nasdaq Composite Index30.46K0.05%-
Spartan Total Market Index Pool E27.29K0.05%-
Vanguard Institutional Extnd Mkt Idx Tr12.46K0.02%-
Fidelity Total Market Index9.78K0.02%-
Spartan Extended Market Index Pool E8.05K0.01%1.22K
Northern Trust Extended Eq Market Idx2.60K0.00%-
NT Ext Equity Mkt Idx Fd - L2.60K0.00%-
NT Ext Eq Mkt Indx Fd DC Lending Tier 5401.000.00%1.00

Recent Insider Transactions

DateNameRoleActivityValue
Feb 15, 2022Hoffman Robert E. President and CEOBuy$25.80K
Dec 08, 2021Praill Anthony Scott Chief Financial OfficerBuy$19.43K
Dec 07, 2021Zarrabian Saiid Head of Strategic PartnershipsBuy$24.30K
Dec 06, 2021Zarrabian Saiid Head of Strategic PartnershipsBuy$7.02K
Nov 22, 2021Johnson Laura L.-Buy$2.23K

Insider Transactions Trends

DateBuySell
2023 Q3--
2023 Q2--
2023 Q1--
2022 Q3--
2022 Q11-

KTRA Ownership FAQ

Who Owns Kintara Therapeutics?

Kintara Therapeutics shareholders are primarily institutional investors at 4.76%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Kintara Therapeutics's industry, Biotech Stocks , is 44.97%, which Kintara Therapeutics falls below.

Does Blackrock own Kintara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Kintara Therapeutics.

Who is the top mutual fund holder of Kintara Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Kintara Therapeutics shares, with 0.57% of its total shares outstanding invested in 314.7K Kintara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools